Azenta completes sale of B Medical Systems for $63M; $35M vendor loan to buyer

Azenta, Inc.

Sale closed July 1, 2026; fixed purchase price $63M: $28M cash at closing, $35M via secured vendor loan.
Vendor loan from Azenta Germany GmbH to Thelema at 6% interest, matures 3 months from funding date.
Thelema majority-owned by Luc Provost (Azenta VP & B Medical CEO); Audit Committee approved related-party terms.
Pro forma balance sheet as of Mar 31, 2026 shows net cash proceeds $19M and $35M note receivable from Thelema.
Azenta CEO states sale simplifies portfolio and positions company for sustainable growth in core life sciences.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.